TransMedics Group Inc (TMDX) — Capital Reinvestment Ratio

Latest as of December 2025: 0.45x

TransMedics Group Inc (TMDX) has a Capital Reinvestment Ratio of 0.45x as of December 2025, meaning it reinvests 0% of its operating cash flow ($34.51 Million) in capital expenditures ($15.51 Million). See TMDX net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.45x

Capex / Operating Cash Flow

Operating Cash Flow

$34.51 Million

USD

Capital Expenditures

$15.51 Million

USD

Data as of

Dec 2025

Most recent filing

TransMedics Group Inc Capital Reinvestment Ratio (2024–2025)

This chart tracks TransMedics Group Inc's Capital Reinvestment Ratio across 2 annual periods. Check TransMedics Group Inc (TMDX) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for TransMedics Group Inc (2024–2025)

Year-by-year Capital Reinvestment Ratio for TransMedics Group Inc from 2024 to 2025. For live market cap and broader valuation context, see TransMedics Group Inc market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2025	0.31x	$192.84 Million	$59.25 Million	▼ -88.4%
2024	2.66x	$48.80 Million	$129.74 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow